Category Archives: Neurology

Common Bacteria Are Evaluated As New Possible Multiple Sclerosis Trigger

Common Bacteria Are Evaluated As New Possible Multiple Sclerosis Trigger

Research on  Multiple Sclerosis (MS) has pointed towards environmental causes, or triggers, to the auto-immune disease.  Most studies looked at infections of the Central Nervous System by viruses [1] such as the: Torque Teno virus, Epstein-Barr virus Human Herpes virus 6 As an illustration of the brain tissue lesions caused …Read the Rest

IN BRIEF: CoEnzyme Q10 Shown To Decrease Fibromyalgia Pain

IN BRIEF: CoEnzyme Q10 Shown To Decrease Fibromyalgia Pain

The journals “Nutrition” [1] and Anti Oxidant Redox [2] recently published articles on the benefits of CoEnzyme Q10 (CoQ10) against Fibromyalgia (FM). The team of researchers is essentially the same in both articles: Cordero MD et al.  What is CoQ10? CoQ10 is a quinone organic compound that  transfers electrons through Reduction/Oxidation …Read the Rest

Vitamin D and Calcitriol Shown As Effective Against A Multiple Sclerosis Model in Mice

Vitamin D and Calcitriol Shown As Effective Against A Multiple Sclerosis Model in Mice

 A new study published in the Journal of Neuroimmunology [1] purports that a combination of vitamin D and Calcitriol (a hormonal for of vitamin D) was effective against Experimental Autoimmune Encephalomyelitis (EAE), an Multiple Sclerosis (MS) model,. The times of India even claimed full remission in the mice… We are …Read the Rest

IN DEPTH: Are Virus Antibodies a Source of Neurodegeneration For Multiple Sclerosis?

IN DEPTH: Are Virus Antibodies a Source of Neurodegeneration For Multiple Sclerosis?

A study on the mechanisms of neurodegeneration  for Multiple Sclerosis caught our attention. We just published a post on Progressive Multiple Sclerosis [1], and the approach of the study published in the Dovepress Journal [2], is a noteworthy additional path to understand Neurodegeneration of the Central Nervous System (CNS). Essentially, the …Read the Rest

IN DEPTH: Review Of 2012 Research On Progressive Multiple Sclerosis

IN DEPTH: Review Of 2012 Research On Progressive Multiple Sclerosis

As many of us know, the neurological disease Multiple Sclerosis (MS)  has multiple forms [1]: Relapsing-Remitting  (RRMS):    Unpredictable attacks (relapses) followed by periods of relative remission with no new signs of disease activity Secondary Progressive (SPMS) :     Neurologic decline without acute relapses: A sign that one is evolving from …Read the Rest

Nanoparticle Research Has Success On Halting Multiple Sclerosis In Animal Model Of Disease

Nanoparticle Research Has Success On Halting Multiple Sclerosis In Animal Model Of Disease

Nanotechnology involves  manipulation of matter on an atomic and molecular scale. This means at  least one dimension of the molecule or structure sized from 1 to 500 nanometres. (a nanometer is one billionth of a meter) It is not the first time that Nanotechnology concepts have been used to attack …Read the Rest

The Double Edge of vitamin D Supplementation: From Heart disease to Multiple Sclerosis

The Double Edge of vitamin D Supplementation: From Heart disease to Multiple Sclerosis

Low blood serum  levels of vitamin D are often associated with  chronic issues as diverse as Multiple Sclerosis and Cardiovascular diseases. Is vitamin D supplementation helpful, and does it carry risks? Let us look first at the role of vitamin D in Cardiovascular diseases: My previous post on the dangers of …Read the Rest

IN BRIEF: Zocor Shown to Slow Disability in Secondary Progressive Multiple Sclerosis

IN BRIEF: Zocor Shown to Slow Disability in Secondary Progressive Multiple Sclerosis

The possible benefits of statin drugs against Multiple Sclerosis ( MS) have been investigated for years, not necessarily with success. Wang and colleagues concluded [1]: “There is no convincing evidence to support the use of either atorvastatin or simvastatin as an adjunctive therapy in MS.” But this was as a supplement …Read the Rest

IN BRIEF: FDA Just Approved Oral Relapsing Multiple Sclerosis Drug Aubagio

IN BRIEF: FDA Just Approved Oral Relapsing Multiple Sclerosis Drug Aubagio

Teriflunomide (Aubagio, Genzyme/Sanofi) is coming into the MS market [1]. It is an oral drug, nice. Efficacy:  “30% lower than the rate for those taking a placebo,” said Russell Katz, MD,”   What does that mean? Maybe not as clear as just a percent reduction in releases, think compounding. Sagepub …Read the Rest

Update In Tinnitus Treatments and Control Techniques (Sep. 2012)

Update In Tinnitus Treatments and Control Techniques (Sep. 2012)

People afflicted with Tinnitus hear one or several phantom sounds on a chronic basis. These sounds, or rather noises, have no real existence outside the patient’s head. This post will discuss new  Tinnitus therapy techniques  that fall  into the followings categories :  Music Therapy,  Phase Shift , Drugs and Pharmacology …Read the Rest

Page 1 of 1112345»...Last »

© 2013-2017 Medical News Digest All Rights Reserved